SpaceX Stock Gains More Than 20% After Market Debut
SpaceX’s IPO on June 12 priced shares at $135 and began trading at $150, closing Friday at $160.95. The stock rose about 19% on day one and was up another ~6% in premarket June 15 near $170. SpaceX raised $75 billion at a $1.77 trillion valuation. Analysts cited elevated valuation; CFRA set a $115 “sell” target and Morningstar called it overvalued. Investors will watch the 180-day lock-up expiry.

Near-term trading is dominated by IPO momentum versus valuation skepticism and the upcoming 180-day lock-up expiration.
SpaceX’s IPO priced at $135 and the stock jumped ~19% on day one, with premarket trading near $170 and lock-up risk ahead.
Elevated volatility likely around lock-up expiry; near-term price action may remain momentum-driven while valuation bears cap upside.
Background
SpaceX held a record-setting IPO on June 12, priced at $135 per share, and began trading the prior Friday.
Why it matters
The text frames the trade as a momentum-driven IPO pop versus valuation skepticism, with a clear future supply overhang when the 180-day lock-up ends.
Market relevance
A high-profile IPO with immediate price momentum and a specific future catalyst (lock-up expiry) creates a tradable volatility window.
Market effects
Highlights investor appetite for commercial space and satellite internet exposure, but also underscores valuation sensitivity in high-profile IPOs.
Primarily US-listed IPO sentiment; may influence broader US growth/IPO risk appetite.
Space/telecom capital-markets narrative could affect global investor positioning toward satellite and launch economics.
Alternative perspectives
Despite the strong debut, valuation-focused notes (CFRA, Morningstar) imply downside risk if post-lock-up selling overwhelms momentum.
The article flags the 180-day lock-up as the key next event; traders may also watch liquidity/float changes and any follow-on analyst coverage updates after debut.
Key entities
- companySpaceX
Commercial space company behind Starlink and reusable rockets; IPO debut drove a >20% post-listing move in the article.
- research_firmCFRA
Initiated coverage with a “sell” rating and a $115 price target, citing elevated valuation.
- research_firmMorningstar
Pre-IPO note estimated fair value around $63 and called the stock overvalued.

